We are live on ! Find out more
APGN

Apexigen, Inc. Common Stock
APGN

Delisted

APGN was delisted on the 22nd of August, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of APGN yet.

APGN Hedge Fund Activity: Q3 2023 in Review

0 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Apexigen, Inc. Common Stock (APGN) for Q3 2023, worth a combined $0 — down 100% from $1.37M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of APGN and 0 opened new positions — a net loss of 17 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Decheng Capital Management III (Cayman), exiting entirely with an estimated $814K sold.

  • 0 institutional investors held Apexigen, Inc. Common Stock (APGN) as of Q3 2023, down from 17 in Q2 2023.
  • Funds reported $0 of Apexigen, Inc. Common Stock stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Apexigen, Inc. Common Stock positions in Q3 2023 and 17 closed out, a net change of -17 holders.
  • The largest Apexigen, Inc. Common Stock seller in Q3 2023 was Decheng Capital Management III (Cayman), an estimated $814K sold.

Based on aggregated 13F filings for Q3 2023.